Carmelo Carlo-Stella

43PUBLICATIONS
179CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oncology and carcinogenesis not elsewhere classifiedHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Sep 30, 2026
Forimtamig, a GPRC5DxCD3 bispecific antibody with a novel 2:1 format, in relapsed/refractory multiple myeloma.

|Sep 16, 2026
T-cell dynamics, CD8/NK ratio and tumor survival hallmarks determine response to T-cell bispecific forimtamig in myeloma.

|Jul 16, 2026
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial.

|Jan 22, 2026
Bendamustine in combination with gemcitabine and vinorelbine as salvage regimen for relapsed or refractory peripheral T-cell lymphomas: A retrospective single-centre experience.

Filippo Bagnoli, Jacopo Calabrese De Feo, Francesca Ricci

|Aug 14, 2025
Camidanlumab tesirine for relapsed or refractory classic Hodgkin lymphoma: a phase 2 study.

Alex F Herrera, Stephen M Ansell, Pier Luigi Zinzani

|Jul 29, 2025
Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19.

Edward Richardson, Clifton C Mo, Eleonora Calabretta

Pageof 8

Frequent Collaborators

8 joint publications

Mehdi Hamadani

5 joint publications

Eleonora Calabretta

5 joint publications

Pierluigi Zinzani

5 joint publications

Paolo Corradini